Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index
- 19 March 2019
- journal article
- research article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 17 (3) , 338-344
Abstract
The aim of this study was to identify patient and tumour factors most frequently associated with high histological grades of canine mast cell tumours (MCTs). Search criteria in a shared database of multiple Animal Referral Hospital locations within Australia generated 400 canine MCTs in 286 patients. Patient and tumour data were extrapolated and the association between a tumour being histologically high grade and patient and tumour factors, including: patient breed, patient gender and neuter status, patient age at MCT excision, tumour location and tumour size was assessed using univariate analysis. The study consisted of 90 (21.9%) tumours meeting histological high‐grade criteria. Shar peis were the most likely breed to have high grade MCTs, whereas the Pug and the Golden Retriever were the least likely breeds to develop high‐grade MCTs. No significant difference in risks could be established between the age at which the tumour was excised, or the gender and neuter status of patients. MCTs of the inguinal region were the most likely single location to be high grade. Tumour size did not influence the likelihood of a tumour being high grade or low grade. The results of this study suggest that patient and tumour factors may play a role in the histological grades of canine MCTs.Keywords
This publication has 39 references indexed in Scilit:
- Canine Subcutaneous Mast Cell TumorsVeterinary Pathology, 2010
- Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological BehaviorVeterinary Pathology, 2010
- Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatmentVeterinary Dermatology, 2008
- Association of Ki67 index with prognosis for intermediate‐grade canine cutaneous mast cell tumours*Veterinary and Comparative Oncology, 2008
- Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisoneBMC Veterinary Research, 2008
- Gender‐medicine aspects in allergologyAllergy, 2008
- Evaluation of risk and clinical outcome of mast cell tumours in pug dogsVeterinary and Comparative Oncology, 2006
- The Role of c-KIT in Tumorigenesis: Evaluation in Canine Cutaneous Mast Cell TumorsNeoplasia, 2006
- Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998–2004)Journal of the American Veterinary Medical Association, 2006
- CUTANEOUS MAST-CELL TUMOURS IN THE DOG, CAT AND OXBritish Journal of Dermatology, 1958